Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymopentin in HIV-1 Infection
NCT00002051Phase 2Completed
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus type 1 infection (HIV-1) comparing Thymopentin with Placebo (2 arms). Primary endpoint: Amount and/or frequency of virus isolation. Status: completed.
02
Drugs
thymopentin
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00002051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002051.